# EDGAR Filing Document

**Accession Number:** 0001715925
**File Stem:** 0001193125-25-245060
**Filing Date:** 2025-10
**Character Count:** 6158
**Document Hash:** 5792fdd686fbe99c7bd3624302c152de
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-245060.hdr.sgml**: 20251021

**ACCESSION NUMBER**: 0001193125-25-245060

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251021

**FILED AS OF DATE**: 20251021

**DATE AS OF CHANGE**: 20251021

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MindWalk Holdings Corp.
- **CENTRAL INDEX KEY:** 0001715925
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39530
- **FILM NUMBER:** 251407004

**BUSINESS ADDRESS:**
- **STREET 1:** INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701
- **BUSINESS PHONE:** 6048060626

**MAIL ADDRESS:**
- **STREET 1:** INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ImmunoPrecise Antibodies Ltd.
- **DATE OF NAME CHANGE:** 20170830

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**Form 6-K** 

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16** 

**OF THE SECURITIES EXCHANGE ACT OF 1934** 

For the month of **<u>October, 2025</u>**.

Commission File Number: **<u>001-39530</u>**

**<u>MindWalk Holdings Corp.</u>** 

**Industrious 823 Congress Ave Suite 300 Austin, Texas 78701**

(Address of principal executive office)

------

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

------

**INCORPORATION BY REFERENCE**

****<br> Exhibits 99.1 of this Form 6-K are incorporated by reference into the Registration Statement on Form S-8 ([<u>File No. 333-290949</u>](https://www.sec.gov/Archives/edgar/data/1715925/000106299325016198/forms8.htm)) and Registration Statements on Form F-3 (File Nos. 333-273197 and [<u>333-281312</u>](https://www.sec.gov/Archives/edgar/data/1715925/000106299324014520/formf3.htm)) of the Registrant, MindWalk Holdings Corp.

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit**<br>| &nbsp;&nbsp;&nbsp;**Description**<br>|
| &nbsp;&nbsp;99.1 | [<u>Report of Voting Results dated October 9, 2025</u>](hyft-ex99_1.htm) |

---

------

**<u>SIGNATURES</u>** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **MINDWALK HOLDINGS CORP.** | **MINDWALK HOLDINGS CORP.** |
| Date: October 21, 2025 |  |  |
|  | By: | /s/ Jennifer Bath<br>|
|  | Name: | Jennifer Bath |
|  | Title: | Chief Executive Officer |

---

------

## Exhibit 99.1

**Report of Voting Results**

**Submitted Pursuant to**

**Section 11.3 of National Instrument 51-102 - *Continuous Disclosure Obligations***

In accordance with Section 11.3 of National Instrument 51-102 - *Continuous Disclosure Obligations*, this report describes the matters voted upon and the outcome of the votes at the annual general meeting of shareholders of MindWalk Holdings Corp. (the "**Corporation**") held on October 9, 2025, via live webcast (the "**Meeting**"). Each of the matters is described in greater detail in the Corporation's management information circular dated September 12, 2025 (the "**Circular**").

(a)The number of directors was set at four. The following are the voting results on this matter:

---

| | | | |
|:---|:---|:---|:---|
| **FOR** | **% FOR** | &nbsp;&nbsp;**AGAINST** | **% AGAINST** |
| &nbsp;&nbsp;**Number of Directors** 10,999,231 | 81.01% | &nbsp;&nbsp;2578940 | 18.99% |

---

(b)In the Circular, management of the Corporation proposed four nominees for election as directors of the Corporation for the ensuing year or until their successors are duly elected or appointed. The Corporation's majority voting policy stipulates that any director nominee who receives more votes withheld than in favor must tender their resignation to the board. In this instance, Kamil Isaev did not achieve the required majority and, in accordance with the policy, submitted his resignation following the meeting. The Board of Directors voted to accept Isaev's resignation, consistent with the Company's governance guidelines and in accordance with the meeting's voting results. The voting results that formed the basis for this decision are summarized below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | <br>**FOR** | **%** <br>**FOR** | <br>**WITHHELD** | **% WITHHELD** |
| **Jennifer Bath** | 14466159 | 82.19% | 3135042 | 17.81% |
| **Kamil Isaev** | 5530006 | 32.31% | 11581891 | 67.68% |
| **Jon Lieber** | 16657783 | 97.34% | 454114 | 2.65% |
| **Dirk Witters** | 13139325 | 76.78% | 3972571 | 23.21% |

---

(c)Davidson & Company LLP was appointed as the Corporation's auditors and the directors were authorized to fix the remuneration to be paid to the auditors. The following are the voting results on this matter:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>**FOR** | **%** <br>**FOR** | <br>**WITHHELD** | **%** <br>**WITHHELD** |
| **Appointment of Auditors** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22371219 | 95.71% | 1001605 | 4.29% |

---

Dated this 9th day of October 2025.

---

| | |
|:---|:---|
| <br>**IMMUNOPRECISE ANTIBODIES LTD.** | <br>**IMMUNOPRECISE ANTIBODIES LTD.** |
| By: | /s/ Jennifer Bath<br>|
| Name: | Jennifer Bath |
| Title: | Chief Executive Officer |

---

------